BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15660048)

  • 21. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
    Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ;
    J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-release metoprolol succinate in chronic heart failure.
    Tangeman HJ; Patterson JH
    Ann Pharmacother; 2003 May; 37(5):701-10. PubMed ID: 12708950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
    Shore S; Aggarwal V; Zolty R
    J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).
    Gottlieb SS; Fisher ML; Kjekshus J; Deedwania P; Gullestad L; Vitovec J; Wikstrand J;
    Circulation; 2002 Mar; 105(10):1182-8. PubMed ID: 11889011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials.
    Frazier CG; Alexander KP; Newby LK; Anderson S; Iverson E; Packer M; Cohn J; Goldstein S; Douglas PS
    J Am Coll Cardiol; 2007 Apr; 49(13):1450-8. PubMed ID: 17397674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
    Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MERIT-HF mortality and morbidity data.
    Hjalmarson A; Fagerberg B
    Basic Res Cardiol; 2000; 95 Suppl 1():I98-103. PubMed ID: 11192362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
    Wikstrand J; Hjalmarson A; Waagstein F; Fagerberg B; Goldstein S; Kjekshus J; Wedel H;
    J Am Coll Cardiol; 2002 Aug; 40(3):491-8. PubMed ID: 12142116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). The International Steering Committee.
    Am J Cardiol; 1997 Nov; 80(9B):54J-58J. PubMed ID: 9375952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.
    Batty JA; Hall AS; White HL; Wikstrand J; de Boer RA; van Veldhuisen DJ; van der Harst P; Waagstein F; Hjalmarson Å; Kjekshus J; Balmforth AJ;
    Clin Pharmacol Ther; 2014 Mar; 95(3):321-30. PubMed ID: 24193112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies.
    Carr AA; Kowey PR; Devereux RB; Brenner BM; Dahlöf B; Ibsen H; Lindholm LH; Lyle PA; Snapinn SM; Zhang Z; Edelman JM; Shahinfar S
    Am J Cardiol; 2005 Dec; 96(11):1530-6. PubMed ID: 16310435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of global region on outcomes in heart failure β-blocker trials.
    O'Connor CM; Fiuzat M; Swedberg K; Caron M; Koch B; Carson PE; Gattis-Stough W; Davis GW; Bristow MR
    J Am Coll Cardiol; 2011 Aug; 58(9):915-22. PubMed ID: 21851879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
    Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
    J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.
    Domanski MJ; Krause-Steinrauf H; Massie BM; Deedwania P; Follmann D; Kovar D; Murray D; Oren R; Rosenberg Y; Young J; Zile M; Eichhorn E;
    J Card Fail; 2003 Oct; 9(5):354-63. PubMed ID: 14583895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.